Am J Epidemiol 2002; 156:204-210.
Copyright © 2002 by the
Johns Hopkins Bloomberg School of Public Health
SPECIAL ARTICLE |
Commentary: Meta-analysis of Individual Participants’ Data in Genetic Epidemiology
1 Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, and Ioannina Biomedical Research Institute, Foundation for Research and Technology–Hellas, Ioannina, Greece.
2 Department of Medicine, Tufts University School of Medicine, Boston, MA.
3 Biostatistics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD.
4 Viral Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD.
Received for publication October 9, 2001; accepted for publication March 14, 2002.
bias, epidemiology; genetics; meta-analysis
Abbreviations: Abbreviations: AIDS, acquired immunodeficiency syndrome; CCR2, C-C chemokine receptor 2; CCR5, C-C chemokine receptor 5; CDC, Centers for Disease Control and Prevention; D32, 32-base pair deletion; HIV-1, human immunodeficiency virus type 1; MIPD, meta-analysis of individual participants’ data; MPL, meta-analysis of the published literature; SDF-1, stromal cell-derived factor 1.
| The first 150 words of the full text of this article appear below. |
 |
INTRODUCTION |
|---|
With more than 30,000 human genes and several genetic markers per gene, the potential for identifying genetic associations for various diseases is enormous (1–5). Genetic effects are often modest: Many subjects must be studied, and single epidemiologic studies are unlikely to be definitive. Meta-analysis may help meet the challenge of synthesizing data from studies of genetic epidemiology (6). Several meta-analyses of published literature (MPL) have already appeared in the field (7). Meta-analysis of epidemiologic studies (8) is controversial. Critics have focused on variability in study designs, poor data quality, insufficient confounder adjustment, publication bias, and spuriously narrow confidence intervals (9–12). Use of the raw information from individual subjects instead of published data avoids some of these problems. Meta-analysis of individual patient data has been applied successfully in randomized trials (13, 14). The equivalent
|
CONDUCT OF THE MPL |
|---|
|
CONDUCT OF THE MIPD |
|---|
|
ADVANTAGES OF MIPD (table 1) |
|---|
Data
Completeness of information
Standardization of information
Analysis
Time-to-event analyses
Adjusted/multivariate analyses
Linkage disequilibrium
Alternative genetic models and effects of multiple genes
Population subgroups
Interpretation
Heterogeneity
Assessing sampling bias
Other
Establishing collaborations
|
DISADVANTAGES OF MIPD (table 1) |
|---|
Data
Interpretation
Resources
|
FINAL COMMENT |
|---|
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Bacci, R. Di Paola, C. Menzaghi, P. Di Fulvio, S. Di Silvestre, F. Pellegrini, R. Baratta, A. Marucci, S. Mastroianno, G. Fini, et al. ENPP1 Q121 Variant, Increased Pulse Pressure and Reduced Insulin Signaling, and Nitric Oxide Synthase Activity in Endothelial Cells Arterioscler Thromb Vasc Biol, October 1, 2009; 29(10): 1678 - 1683. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Liberati, D. G. Altman, J. Tetzlaff, C. Mulrow, P. C. Gotzsche, J. P.A. Ioannidis, M. Clarke, P. J. Devereaux, J. Kleijnen, and D. Moher The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration Ann Intern Med, August 18, 2009; 151(4): W-65 - W-94. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Liberati, D. G Altman, J. Tetzlaff, C. Mulrow, P. C Gotzsche, J. P A Ioannidis, M. Clarke, P J Devereaux, J. Kleijnen, and D. Moher The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration BMJ, July 21, 2009; 339(jul21_1): b2700 - b2700. [Abstract] [Full Text]
|
|
|
|
 |
|
 P. G. Bagos Plasminogen activator inhibitor-1 4G/5G and 5,10-methylene-tetrahydrofolate reductase C677T polymorphisms in polycystic ovary syndrome Mol. Hum. Reprod., January 1, 2009; 15(1): 19 - 26. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. Ioannidis and T. A Trikalinos An exploratory test for an excess of significant findings Clinical Trials, June 1, 2007; 4(3): 245 - 253. [Abstract] [PDF]
|
|
|
|
 |
|
 J. P. A. Ioannidis Common genetic variants for breast cancer: 32 largely refuted candidates and larger prospects. J Natl Cancer Inst, October 4, 2006; 98(19): 1350 - 1353. [Full Text] [PDF]
|
|
|
|
 |
|
 C. Huth, I. M. Heid, C. Vollmert, C. Gieger, H. Grallert, J. K. Wolford, B. Langer, B. Thorand, N. Klopp, Y. H. Hamid, et al. IL6 Gene Promoter Polymorphisms and Type 2 Diabetes: Joint Analysis of Individual Participants' Data From 21 Studies. Diabetes, October 1, 2006; 55(10): 2915 - 2921. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Maraganore, M. de Andrade, A. Elbaz, M. J. Farrer, J. P. Ioannidis, R. Kruger, W. A. Rocca, N. K. Schneider, T. G. Lesnick, S. J. Lincoln, et al. Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease. JAMA, August 9, 2006; 296(6): 661 - 670. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P A Ioannidis Commentary: Grading the credibility of molecular evidence for complex diseases Int. J. Epidemiol., June 1, 2006; 35(3): 572 - 578. [Full Text] [PDF]
|
|
|
|
 |
|
 S. A. Smith-Warner, D. Spiegelman, J. Ritz, D. Albanes, W. L. Beeson, L. Bernstein, F. Berrino, P. A. van den Brandt, J. E. Buring, E. Cho, et al. Methods for Pooling Results of Epidemiologic Studies: The Pooling Project of Prospective Studies of Diet and Cancer Am. J. Epidemiol., June 1, 2006; 163(11): 1053 - 1064. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. A. Ioannidis, J. Bernstein, P. Boffetta, J. Danesh, S. Dolan, P. Hartge, D. Hunter, P. Inskip, M.-R. Jarvelin, J. Little, et al. A Network of Investigator Networks in Human Genome Epidemiology Am. J. Epidemiol., August 15, 2005; 162(4): 302 - 304. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Kyzas, K. T. Loizou, and J. P. A. Ioannidis Selective Reporting Biases in Cancer Prognostic Factor Studies J Natl Cancer Inst, July 20, 2005; 97(14): 1043 - 1055. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M M Rovers, N Black, G G Browning, R Maw, G A Zielhuis, and M P Haggard Grommets in otitis media with effusion: an individual patient data meta-analysis Arch. Dis. Child., May 1, 2005; 90(5): 480 - 485. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Ntais, A. Polycarpou, and J. P.A. Ioannidis Association of GSTM1, GSTT1, and GSTP1 Gene Polymorphisms with the Risk of Prostate Cancer: A Meta-analysis Cancer Epidemiol. Biomarkers Prev., January 1, 2005; 14(1): 176 - 181. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. A. Ioannidis, S. H. Ralston, S. T. Bennett, M. L. Brandi, D. Grinberg, F. B. Karassa, B. Langdahl, J. B. J. van Meurs, L. Mosekilde, S. Scollen, et al. Differential Genetic Effects of ESR1 Gene Polymorphisms on Osteoporosis Outcomes JAMA, November 3, 2004; 292(17): 2105 - 2114. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Ntais, A. Polycarpou, and J. P. A. Ioannidis Vitamin D Receptor Gene Polymorphisms and Risk of Prostate Cancer: A Meta-analysis Cancer Epidemiol. Biomarkers Prev., December 1, 2003; 12(12): 1395 - 1402. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E. Heffner, K. Highland, and L. K. Brown A Meta-analysis Derivation of Continuous Likelihood Ratios for Diagnosing Pleural Fluid Exudates Am. J. Respir. Crit. Care Med., June 15, 2003; 167(12): 1591 - 1599. [Full Text] [PDF]
|
|
|
|
|
|
J. Little, M. J. Khoury, L. Bradley, M. Clyne, M. Gwinn, B. Lin, M.-L. Lindegren, and P. Yoon The Human Genome Project Is Complete. How Do We Develop a Handle for the Pump? Am. J. Epidemiol., April 15, 2003; 157(8): 667 - 673. [Full Text] [PDF]
|
|
|
|
|
|
N. E. Caporaso Why Have We Failed to Find the Low Penetrance Genetic Constituents of Common Cancers? Cancer Epidemiol. Biomarkers Prev., December 1, 2002; 11(12): 1544 - 1549. [Full Text] [PDF]
|
|
|
|
|
|
J. Little, L. Bradley, M. S. Bray, M. Clyne, J. Dorman, D. L. Ellsworth, J. Hanson, M. Khoury, J. Lau, T. R. O'Brien, et al. Reporting, Appraising, and Integrating Data on Genotype Prevalence and Gene-Disease Associations Am. J. Epidemiol., August 15, 2002; 156(4): 300 - 310. [Abstract] [Full Text] [PDF]
|
|